Clinical Trials Browser

Phase 3 × Lymphoma, Large B-Cell, Diffuse × selinexor × Clear all

NCT07011056 2025-09-19

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

Phase 3 Recruiting

Recurrence, Lymphoma, Large B-Cell, Diffuse